Home The Word Brain	My Amedeo FAQ Privacy About
	Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts This week, 27 April 2025: Treatment-resistant hypertension Influenza transmission Nanoplastics in human brains Malaria elimination Chikungunya vaccine

Influenza

Free Subscription Articles published in Virus Res Retrieve available abstracts of 84 articles: HTML format

Single Articles

May 2025
1. YANG W, Tao T, Zhang J, Yao Y, et al
   The association of cycle threshold value with clinical features in patients infected with Omicron variant.
   Virus Res. 2025;355:199565.
   PubMed     Abstract available
   
   
   
2. YAN J, Liu F, Hu S, Pan J, et al
   Regional dynamics and mechanisms behind SARS-CoV-2 XDV.1 prevalence in Chongqing via genomic surveillance and molecular insights.
   Virus Res. 2025;355:199562.
   PubMed     Abstract available
   
   
   
3. ZADEH VR, Lew JM, Zahoor MA, Santer D, et al
   Combination therapy enhances the antiviral activity of IFN-lambda against SARS-CoV-2 and MERS-CoV.
   Virus Res. 2025;355:199560.
   PubMed     Abstract available
   
   
   
4. ZHAO X, Zhu X, Wang J, Ye C, et al
   The epidemiological analysis of respiratory virus infections in Children in Hangzhou from 2019 to 2023.
   Virus Res. 2025;355:199558.
   PubMed     Abstract available
   
   
   April 2025
5. CHEN N, Jin J, Qiao B, Gao Z, et al
   JNK kinase promotes inflammatory responses by inducing the expression of the inflammatory amplifier TREM1 during influenza a virus infection.
   Virus Res. 2025;356:199577.
   PubMed     Abstract available
   
   
   March 2025
6. MYERS ML, Conlon MT, Gallagher JR, Woolfork DD, et al
   Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric states.
   Virus Res. 2025 Mar 24:199563. doi: 10.1016/j.virusres.2025.199563.
   PubMed     Abstract available
   
   
   
7. GHAMMAZ H, Melloul M, Mbarki A, Hemlali M, et al
   Genomic evolution of SARS-CoV-2 in Morocco: Insights from whole genome sequences collected from 2020 to 2024.
   Virus Res. 2025;353:199530.
   PubMed     Abstract available
   
   
   January 2025
8. CHA RM, Park MJ, Baek YG, Lee YN, et al
   Genetic characteristics and pathogenesis of clade 2.3.4.4b H5N1 high pathogenicity avian influenza virus isolated from poultry in South Korea, 2022-2023.
   Virus Res. 2025 Jan 31:199541. doi: 10.1016/j.virusres.2025.199541.
   PubMed     Abstract available
   
   
   
9. EL HOUDI M, Skhoun H, El Fessikh M, Benmansour R, et al
   Association study of the JAK/STAT signaling pathway with susceptibility to COVID-19 in moroccan patient and in-silico analysis of rare variants.
   Virus Res. 2025;351:199509.
   PubMed     Abstract available
   
   
   
10. DEZORDI FZ, Junior JVJS, Ruoso TF, Batista AG, et al
    Higher frequency of interstate over international transmission chains of SARS-CoV-2 virus at the Rio Grande do Sul - Brazil state borders.
    Virus Res. 2025;351:199500.
    PubMed     Abstract available
    
    
    December 2024
11. KOMAMI M, Komu JG, Ishiguro Y, Sasaki M, et al
    Detection of antibodies against H5 subtype highly pathogenic avian influenza viruses in multiple raccoons in Tokachi District, Hokkaido, Japan, from 2022 to 2023.
    Virus Res. 2024 Dec 15:199515. doi: 10.1016/j.virusres.2024.199515.
    PubMed     Abstract available
    
    
    
12. MAO B, Le-Trilling VTK, Tang H, Hu J, et al
    Diphyllin elicits a doubled-pronged attack on the entry of SARS-CoV-2 by inhibiting cathepsin L and furin.
    Virus Res. 2024;350:199485.
    PubMed     Abstract available
    
    
    
13. GIRMA A
    Biology of human respiratory syncytial virus: Current perspectives in immune response and mechanisms against the virus.
    Virus Res. 2024;350:199483.
    PubMed     Abstract available
    
    
    
14. KUROSE M, Yamamoto A, Elsayed AMA, Lawal-Ayinde BM, et al
    Viral coexistence and insertional mutations in the ORF8 region of SARS-CoV-2: A possible mechanism of nucleotide insertion.
    Virus Res. 2024;350:199478.
    PubMed     Abstract available
    
    
    
15. NO JS, Noh JY, Lee CY, Kim IH, et al
    Dynamics of SARS-CoV-2 variants during the XBB wave in the Republic of Korea.
    Virus Res. 2024;350:199471.
    PubMed     Abstract available
    
    
    November 2024
16. DELL'ANNUNZIATA F, Mosidze E, Folliero V, Lamparelli EP, et al
    Eco-friendly synthesis of silver nanoparticles from peel and juice C. limon and their antiviral efficacy against HSV-1 and SARS-CoV-2.
    Virus Res. 2024;349:199455.
    PubMed     Abstract available
    
    
    October 2024
17. ELHUSSEINY MH, Elsayed MM, Mady WH, Mahana O, et al
    Genetic features of avian influenza (A/H5N8) clade 2.3.4.4b isolated from quail in Egypt.
    Virus Res. 2024;350:199482.
    PubMed     Abstract available
    
    
    
18. PAZ M, Franco-Trecu V, Szteren D, Costabile A, et al
    Understanding the emergence of highly pathogenic avian Influenza A virus H5N1 in pinnipeds: an evolutionary approach.
    Virus Res. 2024 Oct 1:199472. doi: 10.1016/j.virusres.2024.199472.
    PubMed     Abstract available
    
    
    September 2024
19. KO EA, Zhou T, Ko JH
    Insight into noncanonical small noncoding RNAs in Influenza A virus infection.
    Virus Res. 2024;350:199474.
    PubMed     Abstract available
    
    
    
20. SONDLANE H, Ogunbayo A, Donato C, Mogotsi M, et al
    Whole genome molecular analysis of respiratory syncytial virus pre and during the COVID-19 pandemic in Free State province, South Africa.
    Virus Res. 2024;347:199421.
    PubMed     Abstract available
    
    
    August 2024
21. LEIST SR, Schafer A, Risemberg EL, Bell TA, et al
    Sarbecovirus disease susceptibility is conserved across viral and host models.
    Virus Res. 2024;346:199399.
    PubMed     Abstract available
    
    
    July 2024
22. WANG Y, Yu H, Zhang T, Sun Z, et al
    Associations between genetic mutations in different SARS-CoV-2 strains and negative conversion time of viral RNA among imported cases in Hangzhou: A cross-sectional study.
    Virus Res. 2024;345:199400.
    PubMed     Abstract available
    
    
    
23. CHIEN Y, Huang XY, Yarmishyn AA, Chien CS, et al
    Paracrinal regulation of neutrophil functions by coronaviral infection in iPSC-derived alveolar type II epithelial cells.
    Virus Res. 2024;345:199391.
    PubMed     Abstract available
    
    
    
24. CHIRUMBOLO S, Franzini M, Tirelli U
    Does PI-ME/CFS recall post-COVID (PASC) syndrome?
    Virus Res. 2024;345:199393.
    PubMed    
    
    
    
25. BAI H, Zhang X, Gong T, Ma J, et al
    A systematic mutation analysis of 13 major SARS-CoV-2 variants.
    Virus Res. 2024;345:199392.
    PubMed     Abstract available
    
    
    June 2024
26. TAKADATE Y, Mine J, Tsunekuni R, Sakuma S, et al
    Genetic diversity of H5N1 and H5N2 high pathogenicity avian influenza viruses isolated from poultry in Japan during the winter of 2022-2023.
    Virus Res. 2024;347:199425.
    PubMed     Abstract available
    
    
    
27. RIVETTI AV JR, Reischak D, de Oliveira CHS, Otaka JNP, et al
    Phylodynamics of avian influenza A(H5N1) viruses from outbreaks in Brazil.
    Virus Res. 2024;347:199415.
    PubMed     Abstract available
    
    
    
28. KHAIRNAR K, Tomar SS
    COVID-19 genome surveillance: A geographical landscape and mutational mapping of SARS-CoV-2 variants in central India over two years.
    Virus Res. 2024;344:199365.
    PubMed     Abstract available
    
    
    
29. LUO L, Lv J
    An evolutionary theory on virus mutation in COVID-19.
    Virus Res. 2024;344:199358.
    PubMed     Abstract available
    
    
    
30. SCHAFER A, Gralinski LE, Leist SR, Hampton BK, et al
    Genetic loci regulate Sarbecovirus pathogenesis: A comparison across mice and humans.
    Virus Res. 2024;344:199357.
    PubMed     Abstract available
    
    
    
31. SCHMITZ T, Freuer D, Gosslau Y, Warm TD, et al
    Can inflammatory plasma proteins predict Long COVID or Fatigue severity after SARS-CoV-2 infection?
    Virus Res. 2024;344:199363.
    PubMed     Abstract available
    
    
    
32. KHEMIRI H, Mangone I, Gdoura M, Mefteh K, et al
    Dynamic of SARS-CoV-2 variants circulation in Tunisian pediatric population, during successive waves, from March 2020 to September 2022.
    Virus Res. 2024;344:199353.
    PubMed     Abstract available
    
    
    May 2024
33. XU C, Wang Z, Yu B, Pan Z, et al
    Simultaneous and ultrafast detection of pan-SARS-coronaviruses and influenza A/B viruses by a novel multiplex real-time RT-PCR assay.
    Virus Res. 2024 May 28:199410. doi: 10.1016/j.virusres.2024.199410.
    PubMed     Abstract available
    
    
    
34. LIN X, Yang F, Yan S, Wu H, et al
    Preparation and characterization of mouse-derived monoclonal antibodies against the hemagglutinin of the H1N1 influenza virus.
    Virus Res. 2024;345:199402.
    PubMed     Abstract available
    
    
    
35. WU CC, Tam EH, Shih YY, Lin YR, et al
    Exploration of influenza A virus PA protein-associated cellular proteins discloses its impact on mitochondrial function.
    Virus Res. 2024 May 6:199387. doi: 10.1016/j.virusres.2024.199387.
    PubMed     Abstract available
    
    
    
36. GLENET M, Lebreil AL, N'Guyen Y, Meyer I, et al
    Structural impact of a new spike Y170W mutation detected in early emerging SARS-CoV-2 Omicron variants in France.
    Virus Res. 2024;343:199354.
    PubMed     Abstract available
    
    
    
37. KUZIKOV M, Reinshagen J, Wycisk K, Corona A, et al
    Drug repurposing screen to identify inhibitors of the RNA polymerase (nsp12) and helicase (nsp13) from SARS-CoV-2 replication and transcription complex.
    Virus Res. 2024;343:199356.
    PubMed     Abstract available
    
    
    April 2024
38. WANG Z, Sun W, Li D, Sun Y, et al
    A live attenuated influenza B virus vaccine expressing RBD elicits protective immunity against SARS-CoV-2 in mice.
    Virus Res. 2024;345:199378.
    PubMed     Abstract available
    
    
    
39. PAYEN SH, Adhikari K, Petereit J, Uppal T, et al
    SARS-CoV-2 superinfection in CD14(+) monocytes with latent human cytomegalovirus (HCMV) promotes inflammatory cascade.
    Virus Res. 2024;345:199375.
    PubMed     Abstract available
    
    
    
40. LIU D, Leung KY, Lam HY, Zhang R, et al
    Interaction and antiviral treatment of coinfection between SARS-CoV-2 and influenza in vitro.
    Virus Res. 2024;345:199371.
    PubMed     Abstract available
    
    
    
41. ZHANG S, Wang P, Shi L, Wang C, et al
    Exploring COVID-19 causal genes through disease-specific Cis-eQTLs.
    Virus Res. 2024;342:199341.
    PubMed     Abstract available
    
    
    
42. MONTENEGRO AFL, Clementino MAF, Yaochite JNU
    Type I interferon pathway genetic variants in severe COVID-19.
    Virus Res. 2024;342:199339.
    PubMed     Abstract available
    
    
    
43. LIM T, Rajoriya S, Kim B, Natasha A, et al
    In vitro broad-spectrum antiviral activity of MIT-001, a mitochondria-targeted reactive oxygen species scavenger, against severe acute respiratory syndrome coronavirus 2 and multiple zoonotic viruses.
    Virus Res. 2024;342:199325.
    PubMed     Abstract available
    
    
    March 2024
44. JANSEN JM, Meineke R, Molle A, van de Sandt CE, et al
    Selective pressure mediated by influenza virus M1(58-66) epitope-specific CD8(+)T cells promotes accumulation of extra-epitopic amino acid substitutions associated with viral resistance to these T cells.
    Virus Res. 2024;343:199355.
    PubMed     Abstract available
    
    
    
45. LARBI I, Marwa A, Souai O, Tougorti H, et al
    Phylogeographic Dynamics of H9N2 Avian Influenza Viruses in Tunisia.
    Virus Res. 2024 Mar 9:199348. doi: 10.1016/j.virusres.2024.199348.
    PubMed     Abstract available
    
    
    
46. WANG X, Cheng J, Shen L, Chen M, et al
    Rab5c promotes RSV and ADV replication by autophagy in respiratory epithelial cells.
    Virus Res. 2024;341:199324.
    PubMed     Abstract available
    
    
    
47. HUANG X, Kantonen J, Nowlan K, Nguyen NA, et al
    Mucosal-Associated Invariant T Cells are not susceptible in vitro to SARS-CoV-2 infection but accumulate into the lungs of COVID-19 patients.
    Virus Res. 2024;341:199315.
    PubMed     Abstract available
    
    
    February 2024
48. LI ZA, Bajpai AK, Wang R, Liu Y, et al
    Systems Genetics of Influenza A Virus-infected Mice Identifies TRIM21 as a Critical Regulator of Pulmonary Innate Immune Response.
    Virus Res. 2024 Feb 6:199335. doi: 10.1016/j.virusres.2024.199335.
    PubMed     Abstract available
    
    
    
49. CEBALLOS-GARZON A, Comtet-Marre S, Peyret P
    Applying targeted gene hybridization capture to viruses with a focus to SARS-CoV-2.
    Virus Res. 2024;340:199293.
    PubMed     Abstract available
    
    
    
50. ZHANG DQ, Ma QH, Yang MC, Belyakova YY, et al
    Peroxide derivatives as SARS-CoV-2 entry inhibitors.
    Virus Res. 2024;340:199295.
    PubMed     Abstract available
    
    
    
51. DE ALMEIDA MARQUES DP, Andrade LAF, Reis EVS, Clarindo FA, et al
    New anti-SARS-CoV-2 aminoadamantane compounds as antiviral candidates for the treatment of COVID-19.
    Virus Res. 2024;340:199291.
    PubMed     Abstract available
    
    
    January 2024
52. KODSI IA, Rayes DE, Koweyes J, Khoury CA, et al
    Tracking SARS-CoV-2 variants during the 2023 flu season and beyond in Lebanon.
    Virus Res. 2024;339:199289.
    PubMed     Abstract available
    
    
    
53. CHRIST W, Klingstrom J, Tynell J
    SARS-CoV-2 variant-specific differences in inhibiting the effects of the PKR-activated integrated stress response.
    Virus Res. 2024;339:199271.
    PubMed     Abstract available
    
    
    
54. CAI Z, Bai H, Ren D, Xue B, et al
    Integrin alphavbeta1 facilitates ACE2-mediated entry of SARS-CoV-2.
    Virus Res. 2024;339:199251.
    PubMed     Abstract available
    
    
    
55. ESSAIDI-LAZIOSI M, Perez-Rodriguez FJ, Alvarez C, Sattonnet-Roche P, et al
    Distinct phenotype of SARS-CoV-2 Omicron BA.1 in human primary cells but no increased host range in cell lines of putative mammalian reservoir species.
    Virus Res. 2024;339:199255.
    PubMed     Abstract available
    
    
    December 2023
56. KRISTENSEN C, Larsen LE, Trebbien R, Jensen HE, et al
    The avian influenza A virus receptor SA-alpha2,3-Gal is expressed in the porcine nasal mucosa sustaining the pig as a mixing vessel for new influenza viruses.
    Virus Res. 2023 Dec 22:199304. doi: 10.1016/j.virusres.2023.199304.
    PubMed     Abstract available
    
    
    
57. OTA K, Sakai H, Sasaki D, Mitsumoto-Kaseida F, et al
    Rapid increase in salivary IgA and broad recognition of spike protein following SARS-CoV-2 vaccination.
    Virus Res. 2023 Dec 4:199294. doi: 10.1016/j.virusres.2023.199294.
    PubMed     Abstract available
    
    
    November 2023
58. LI X, Ye Z, Plant EP
    5' copyback defective viral genomes are major component in clinical and non-clinical influenza samples.
    Virus Res. 2023;339:199274.
    PubMed     Abstract available
    
    
    October 2023
59. NEDAEI F, Esmaeili Rastaghi AR, Goodarzi E, Haji Mullah Asadullah H, et al
    Introduction and effect of natural selection analysis at common mutations of SARS-CoV-2 spike gene in Iran.
    Virus Res. 2023;336:199202.
    PubMed     Abstract available
    
    
    
60. RAHNI Z, Hosseini SM, Shahrokh S, Saeedi Niasar M, et al
    Long non-coding RNAs ANRIL, THRIL, and NEAT1 as potential circulating biomarkers of SARS-CoV-2 infection and disease severity.
    Virus Res. 2023;336:199214.
    PubMed     Abstract available
    
    
    
61. SCHINDEWOLF C, Menachery VD
    Coronavirus 2'-O-methyltransferase: A promising therapeutic target.
    Virus Res. 2023;336:199211.
    PubMed     Abstract available
    
    
    
62. CAO J, Gu H, Zhang X, Yun H, et al
    Intranasal inoculation of female BALB/c mice with replication-deficient human adenovirus type 5 expressing SARS-CoV-2 nucleocapsid protein aggravates lung pathology upon re-encountering the antigen.
    Virus Res. 2023;335:199201.
    PubMed     Abstract available
    
    
    September 2023
63. TAKAZAWA S, Kotaki T, Nakamura S, Utsubo C, et al
    Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities.
    Virus Res. 2023;334:199176.
    PubMed     Abstract available
    
    
    
64. STINCARELLI MA, Quagliata M, Di Santo A, Pacini L, et al
    SARS-CoV-2 inhibitory activity of a short peptide derived from internal fusion peptide of S2 subunit of spike glycoprotein.
    Virus Res. 2023;334:199170.
    PubMed     Abstract available
    
    
    
65. ANDRADE-MOLINA DA, Morey-Leon GA, Munoz-Mawyin KE, Cruz-Fatuly FF, et al
    First sequenced cases of Omicron BA.2 sublineage in Ecuador.
    Virus Res. 2023;334:199169.
    PubMed     Abstract available
    
    
    
66. WANG Z, Pan Q, Ma L, Zhao J, et al
    Anthracyclines inhibit SARS-CoV-2 infection.
    Virus Res. 2023;334:199164.
    PubMed     Abstract available
    
    
    
67. BERNAL KDE, Whitehurst CB
    Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients.
    Virus Res. 2023;334:199157.
    PubMed     Abstract available
    
    
    
68. STRAKOVA P, Bednar P, Kotoucek J, Holoubek J, et al
    Antiviral activity of singlet oxygen-photogenerating perylene compounds against SARS-CoV-2: Interaction with the viral envelope and photodynamic virion inactivation.
    Virus Res. 2023;334:199158.
    PubMed     Abstract available
    
    
    August 2023
69. LEE MM, Cho WK, Cha MH, Yim NH, et al
    The antiviral activity of Thuja orientalis folium against Influenza A virus.
    Virus Res. 2023 Aug 13:199199. doi: 10.1016/j.virusres.2023.199199.
    PubMed     Abstract available
    
    
    
70. TAKAHASHI T, Akagawa M, Kimura R, Sada M, et al
    Molecular evolutionary analyses of the fusion protein gene in human respirovirus 1.
    Virus Res. 2023;333:199142.
    PubMed     Abstract available
    
    
    
71. KO MK, Kim HW, Park SH, Park JH, et al
    The role of zinc sulfate in enhancing cellular and humoral immune responses to foot-and-mouth disease vaccine.
    Virus Res. 2023 Aug 1:199189. doi: 10.1016/j.virusres.2023.199189.
    PubMed     Abstract available
    
    
    July 2023
72. MOEINI S, Mohebbi A, Farahmand B, Mehrbod P, et al
    Phylogenetic analysis and docking study of neuraminidase gene of influenza A/H1N1 viruses circulating in Iran from 2010 to 2019.
    Virus Res. 2023 Jul 23:199182. doi: 10.1016/j.virusres.2023.199182.
    PubMed     Abstract available
    
    
    
73. PRINS MLM, Prins C, de Vries JJC, Visser LG, et al
    Establishing immunogenicity and safety of needle-free intradermal delivery by nanoporous ceramic skin patch of mRNA SARS-CoV-2 vaccine as a revaccination strategy in healthy volunteers.
    Virus Res. 2023 Jul 18:199175. doi: 10.1016/j.virusres.2023.199175.
    PubMed     Abstract available
    
    
    
74. GORI SAVELLINI G, Anichini G, Cusi MG
    SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells.
    Virus Res. 2023;332:199134.
    PubMed     Abstract available
    
    
    
75. LI J, Li X, Mao H, Huang C, et al
    SARS-CoV-2 omicron BA.1.1 is highly resistant to antibody neutralization of convalescent serum from the origin strain.
    Virus Res. 2023;332:199131.
    PubMed     Abstract available
    
    
    June 2023
76. JITOBAOM K, Sirihongthong T, Boonarkart C, Phakaratsakul S, et al
    Human Schlafen 11 inhibits influenza A virus production.
    Virus Res. 2023;334:199162.
    PubMed     Abstract available
    
    
    
77. TAI W, Zheng J, Zhang X, Shi J, et al
    MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection.
    Virus Res. 2023;334:199156.
    PubMed     Abstract available
    
    
    May 2023
78. ROY A, Sarkar A, Nayak D, Das S, et al
    Ultradiluted SARS-CoV-2 Spike Protein mitigates hyperinflammation in lung via ferritin and MMP-9 regulation in BALB/c mice.
    Virus Res. 2023;329:199091.
    PubMed     Abstract available
    
    
    April 2023
79. NIE Y, Mou L, Long Q, Deng D, et al
    SARS-CoV-2 ORF3a positively regulates NF-kappaB activity by enhancing IKKbeta-NEMO interaction.
    Virus Res. 2023;328:199086.
    PubMed     Abstract available
    
    
    
80. CUI X, Wang Y, Zhai J, Xue M, et al
    Future trajectory of SARS-CoV-2: Constant spillover back and forth between humans and animals.
    Virus Res. 2023;328:199075.
    PubMed     Abstract available
    
    
    
81. CASTILLO G, Mora-Diaz JC, Breuer M, Singh P, et al
    Molecular mechanisms of human coronavirus NL63 infection and replication.
    Virus Res. 2023;327:199078.
    PubMed     Abstract available
    
    
    
82. KLESTOVA Z
    Possible spread of SARS-CoV-2 in domestic and wild animals and body temperature role.
    Virus Res. 2023;327:199066.
    PubMed     Abstract available
    
    
    
83. TALUKDAR SN, Osan J, Ryan K, Grove B, et al
    RSV-induced expanded ciliated cells contribute to bronchial wall thickening.
    Virus Res. 2023;327:199060.
    PubMed     Abstract available
    
    
    
84. ANDRES C, Del Cuerpo M, Rabella N, Pinana M, et al
    Detection of reassortant influenza B strains from 2004 to 2015 seasons in Barcelona (Catalonia, Spain) by whole genome sequencing.
    Virus Res. 2023 Apr 1:199089. doi: 10.1016/j.virusres.2023.199089.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.